ATYR Q4 2023 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$407,000

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$659,000

Balance Sheet

Total Assets

$121M

Total Liabilities

$30M

Stockholders' Equity

$91M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$10M	-100.0%
Gross Profit	-$407,000	$10M	-104.2%
Operating Income	-$16M	-$8M	-100.7%
Net Income	-$15M	-$8M	-96.3%